- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT04317443
A Prospective Observational Comparison of SMP and ESWL for the Treatment of Renal Stones ≥20 mm in Children (IAU-04)
April 28, 2020 updated by: The International Alliance of Urolithiasis
A Prospective Observational Comparison of Super-mini Percutaneous Nephrolithotomy (SMP) and Extracorporeal Shock Wave Lithotripsy (ESWL) for the Treatment of Renal Stones ≥20 mm in Children: An IAU Study
ESWL and PNL are the two treatment modalities for kidney stones greater than 20 mm in the pediatric population.
ESWL is non-invasive, does not require anesthesia and inexpensive, but its success rate may be lower, and require multiple treatment sessions.
On the contrary, PNL has a higher success rate, does not require multiple sessions but is an invasive method.
Compared to standard PNL, miniaturized PNL systems have been shown to decrease complications with comparable success rates.
SMP is a unique miniaturized PNL system with integrated active irrigation and suction systems.
The current literature lacks studies comparing SMP and ESWL prospectively in the pediatric population.
In this study, the effectiveness, reliability, and reusability of ESWL and SMP will be compared.
Study Overview
Status
Unknown
Conditions
Detailed Description
To compare the success and complication rates of super-mini-percutaneous nephrolithotomy (SMP) and Extracorporeal Shock Wave Lithotripsy (ESWL) for the treatment of renal stones ≥20 mm in children.An international multicentre, prospective, observational study.
Pediatric cases with renal Stones ≥20 mm who undergo ESWL or SMP will be evaluated and compared proespectively.
The total number of departments planned to be included in the study is 10 and the number of cases is 180.
Study Type
Observational
Enrollment (Anticipated)
250
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
No older than 14 years (CHILD)
Accepts Healthy Volunteers
Yes
Genders Eligible for Study
All
Sampling Method
Probability Sample
Study Population
Pediatric patients undergoing SWL and SMP
Description
Inclusion Criteria:
- Children ≤14 years old with renal Stones ≥20 mm
- Willing and able to sign informed consent
- Normal renal function
- No stone-related surgical history
- American Society of Anesthesiology (ASA) score 1-2
Exclusion Criteria:
- Congenital renal anomalies (horseshoe kidney, ureteropelvic junction obstruction)
- Uncorrected UTI
- Abnormal coagulation function
- Morbid obese children (BMI≥35)
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
Cohorts and Interventions
Group / Cohort |
Intervention / Treatment |
---|---|
Super-Mini Percutaneous Nephrolithotomy
Patients undergo SMP
|
SMP will be performed under general anesthesia in prone/supine position.
Renal puncture will be performed under ultrasound/fluoroscopy guidance based on the preference of the participating surgeon.
Tracts will be dilated to 14 Fr.
Stone fragmentation will be performed with holmium laser and fragments will be extracted with the active suction system.
For the exit strategy, placement of a nephrostomy tube or JJ stent will be decided by the participating surgeon.
|
Extracorporeal Shock Wave Lithotripsy
Patients undergo ESWL
|
ESWL will be performed under sedation/analgesia, shock wave lithotripsy parameters will be determined based on the device and the settings of local center.
For patients requiring multiple sessions, maximum 3 (or more) sessions will be allowed.
Ureteral stenting prior to ESWL will be performed based on the decision of the participating center.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Stone free rate
Time Frame: 3-months
|
Stone clearance on the computed tomography (2mm thickness)
|
3-months
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
blood loss
Time Frame: Postoperative day 1
|
Number of participants requiring blood transfusion after the procedure
|
Postoperative day 1
|
auxiliary procedures
Time Frame: Postoperative month 3
|
Number of patients requiring additional auxiliary procedures such as second look PCNL, SWL, Ureteroscopy
|
Postoperative month 3
|
hospital stay
Time Frame: Postoperative month 3
|
From date of admission until the date of discharge,length of hospital stay
|
Postoperative month 3
|
complications
Time Frame: Postoperative month 3
|
Rate of postoperative complications using the Clavien-Dindo system
|
Postoperative month 3
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (ANTICIPATED)
May 1, 2020
Primary Completion (ANTICIPATED)
May 1, 2021
Study Completion (ANTICIPATED)
September 1, 2021
Study Registration Dates
First Submitted
March 11, 2020
First Submitted That Met QC Criteria
March 19, 2020
First Posted (ACTUAL)
March 23, 2020
Study Record Updates
Last Update Posted (ACTUAL)
April 30, 2020
Last Update Submitted That Met QC Criteria
April 28, 2020
Last Verified
April 1, 2020
More Information
Terms related to this study
Keywords
Additional Relevant MeSH Terms
Other Study ID Numbers
- 2020-01
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
NO
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
No
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Kidney Stone
-
Washington University School of MedicineRecruiting
-
Société Internationale d'UrologieCompletedStone Ureter | Stone, Kidney | Stone;RenalUnited States, China, Korea, Republic of, Malaysia, Saudi Arabia, Greece, India, Indonesia, Iran, Islamic Republic of, Iraq, Kenya, Romania, South Africa, Taiwan, Turkey
-
Wake Forest University Health SciencesCogenix Medical CorporationWithdrawnKidney Stone | Renal Stone | Ureter StoneUnited States
-
Advance Shockwave Technology GmbHUnknownKidney StonesUnited States
-
Mansoura UniversityCompletedUrologic Diseases | Stone, Kidney | Stone, Urinary | ESWL | Radiolucent Calculus of Urinary Tract | DissolutionEgypt
-
University of British ColumbiaActive, not recruiting
-
Mansoura UniversityUnknownUrologic Diseases | Stones, Kidney | Stone, Urinary | Shock Wave LithotripsyEgypt
-
Selcuk UniversityThe Scientific and Technological Research Council of TurkeySuspendedKidney StonesTurkey
-
Mansoura UniversityCompleted
-
Alnylam PharmaceuticalsTerminatedRecurrent Calcium Oxalate Kidney Stone Disease | Elevated Urinary Oxalate LevelsUnited States, Italy, Spain, Belgium, Switzerland, United Kingdom
Clinical Trials on Super-mini percutaneous nephrolithotomy (SMP)
-
The First Affiliated Hospital of Guangzhou Medical...Unknown
-
The First Affiliated Hospital of Guangzhou Medical...Completed
-
The First Affiliated Hospital of Guangzhou Medical...General Hospital of Shenyang Military Region; First Affiliated Hospital of... and other collaboratorsCompletedKidney CalculiChina
-
Ain Shams UniversityRecruiting
-
The First Affiliated Hospital of Guangzhou Medical...The First Affiliated Hospital of Anhui Medical University; The First Affiliated... and other collaboratorsNot yet recruitingKidney CalculiChina
-
Mansoura UniversityUnknownNephrolithiasis | Urolithiasis | PCNL | Stone;Renal | PNL | NEPHROLITHOTOMY | MINIPERCEgypt
-
Thunder Bay Regional Health Research InstituteRecruiting
-
Haseki Training and Research HospitalCompleted
-
Ain Shams UniversityRecruiting
-
Isfahan University of Medical SciencesShahid Beheshti University of Medical SciencesCompleted